Grant: Collaborative Research and Development Grants
University of Ottawa
$112,000.00
How does cannabis chemistry impact anti-inflammatory activity? Investigating the entourage effect hypothesis to inform product development and consumer choice_x000d_ _x000d_
FY 2020-21
Summary
Varying with plant genetics, growing conditions, harvest and post-harvest processing, the chemistry of cannabis is complex and leads to complex pharmacology. In addition to the predominant cannabinoids THC and CBD, cannabis contains a variety of other compounds with potential therapeutic effects. The complexity and diversity of cannabis chemistry present a challenge for industry in terms of quality assurance yet offer great opportunity for process optimization and the development of higher quality products.
Canopy Health Innovations (CHI) is biopharmaceutical company focused on developing innovative cannabis-based products with the goal of developing a range of effective formulations and delivery mechanisms to serve patients in Canada and worldwide. CHI seeks to better understand how processing influences product chemistry and bioactivity in order to improve the understanding of cannabis-based medicines and products.
The proposed research includes two complementary projects aiming to characterize the chemistry and pharmacology of different cannabis-derived extracts; the first focuses on operational impacts of extraction and processing while the second focuses on differences between cannabis strains. By tracking the fate of major cannabinoids, terpenes, and other molecules from plant material to commercial products, CHI will gain superior knowledge of cannabis as well as opportunities to optimize operations, develop new value-added products, and strengthen internal quality control. At the population level, Canadian patients and consumers will benefit from safer, more effective, and more consistent cannabis products as well as better evidence on which to base their decisions. At the industry level, our results will inform and elevate R&D activities across Canada, where the established cannabis industry can continue to build competitive advantage and secure its leadership on the global stage.
Program
Collaborative Research and Development Grants
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
543338-2019
Name nom
Harris, Cory
Department département
Biology
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2019
Award amount
112000
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
103
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Plant production and plant primary products
Area of application fr
Production végétale et produits végétaux primaires
Research subject code
3701
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Natural products
Research subject fr
Produits naturels
Installment
inst:2 - 2
Partie
1
Nb partie
2
Application title
How does cannabis chemistry impact anti-inflammatory activity? Investigating the entourage effect hypothesis to inform product development and consumer choice_x000d_
_x000d_
Keyword
NSERC
Application summary
Varying with plant genetics, growing conditions, harvest and post-harvest processing, the chemistry of cannabis is complex and leads to complex pharmacology. In addition to the predominant cannabinoids THC and CBD, cannabis contains a variety of other compounds with potential therapeutic effects. The complexity and diversity of cannabis chemistry present a challenge for industry in terms of quality assurance yet offer great opportunity for process optimization and the development of higher quality products.
Canopy Health Innovations (CHI) is biopharmaceutical company focused on developing innovative cannabis-based products with the goal of developing a range of effective formulations and delivery mechanisms to serve patients in Canada and worldwide. CHI seeks to better understand how processing influences product chemistry and bioactivity in order to improve the understanding of cannabis-based medicines and products.
The proposed research includes two complementary projects aiming to characterize the chemistry and pharmacology of different cannabis-derived extracts; the first focuses on operational impacts of extraction and processing while the second focuses on differences between cannabis strains. By tracking the fate of major cannabinoids, terpenes, and other molecules from plant material to commercial products, CHI will gain superior knowledge of cannabis as well as opportunities to optimize operations, develop new value-added products, and strengthen internal quality control. At the population level, Canadian patients and consumers will benefit from safer, more effective, and more consistent cannabis products as well as better evidence on which to base their decisions. At the industry level, our results will inform and elevate R&D activities across Canada, where the established cannabis industry can continue to build competitive advantage and secure its leadership on the global stage.